Rodin Therapeutics

Developer of Epigenetic modulators for the treatment of CNS disorders

placeCambridge, Massachusetts, United States calendar_todayFounded 2013 groups13 employees language rodintherapeutics.com

Registered entities

Innovation

9 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,946 times.

YearFilings
20151
20173
20184
20194
20205
20216
20222
20233
20251

Investor mix

10 investors on record; lead investors include Atlas Venture, Johnson & Johnson Innovation – JJDC; 1 has since exited.

Investor typeCountShare
Venture capital660%
Private equity110%
Accelerator & incubator110%
Other / undisclosed220%
Coming soon